GlassScriptPhysician profile
Mary Leigh Forehand
NPI 1134181225
$2,341.40
in general payments reported to CMS, 2019-2025
24 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $308 · 2021: $490 · 2022: $399 · 2023: $169 · 2024: $124 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $430.13 | 2019-2023 | Dyanavel Xr |
| Neos Therapeutics, LP | $355.35 | 2019-2024 | Adzenys Xr-Odt |
| Supernus Pharmaceuticals, INC. | $231.46 | 2021-2023 | Qelbree |
| Adlon Therapeutics L.P. | $200.13 | 2019-2021 | |
| Glaxosmithkline, LLC. | $180.18 | 2019-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $178.20 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $160.28 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $158.94 | 2019-2024 | Jornay Pm |
| Sobi, INC | $72.62 | 2019-2023 | |
| Corium, LLC | $49.02 | 2025 | Azstarys |
| Sanofi Pasteur INC. | $46.57 | 2021-2024 | |
| Pfizer INC. | $35.20 | 2020-2025 | |
| Aytu Biopharma, INC. | $34.38 | 2020 | |
| Genentech USA, INC. | $31.49 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $27.79 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $24.33 | 2025 | |
| Organon LLC | $19.32 | 2025 | |
| Verrica Pharmaceuticals INC. | $18.15 | 2024 | Ycanth |
| Collegium Pharmaceutical, INC. | $15.50 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $15.47 | 2019 | |
| Kaleo, INC. | $15.15 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.83 | 2025 | Zoryve |
| Shire North American Group INC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Forehand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.